Literature DB >> 34532120

Hypoxia promotes pancreatic cancer cell migration, invasion, and epithelial-mesenchymal transition via modulating the FOXO3a/DUSP6/ERK axis.

Hua Zhao1, Wei Chen2, Yi Zhu1, Jianying Lou1.   

Abstract

BACKGROUND: Pancreatic cancer (PC) is among the most aggressive types of cancer. Hypoxia has been identified as a key risk factor for cancer progression. The forkhead box (FOX) proteins are multidirectional transcriptional factors that are strongly implicated in malignancies. However, whether FOXO3a, a member of the FOX protein family, is involved in the pro-oncogenic functions of hypoxia in PC has remained largely unelucidated. In this study, we attempted to clarify the role of FOXO3a in metastasis under hypoxic conditions and its underlying mechanism.
METHODS: MTT and flow cytometry assays were performed to detect the cell proliferation and cell cycle distribution respectively. Transwell assays were used to determine the potential of cell migration and invasion. qPCR and western blot assays were used to assess the expression of mRNA and protein. Immunofluorescence assay was performed to evaluate the cellular localization of FOXO3a. FOXO3a overexpression plasmid was constructed to perform the rescue experiment.
RESULTS: Our data indicated that PANC-1 and SW1990 cells represented enhanced cell migration and invasion abilities under hypoxia, while no statistical differences in cell proliferation and cell cycle distribution were observed. Hypoxia upregulated the messenger RNA (mRNA) and protein expressions of HIF-1α, FOXO3a, and the key epithelial-mesenchymal transition (EMT)-related (EMT) molecules N-cadherin and vimentin, as well as the phosphorylation of FOXO3a. Interestingly, hypoxia promoted the extranuclear localization of FOXO3a. Overexpression of FOXO3a not only significantly decreased the invasion, migration, and EMT of PC cell lines, but also reversed hypoxia-induced extranuclear localization. Finally, FOXO3a might act as a tumor suppressor in PC by inhibiting the ERK signaling pathway by inducing DUSP6 expression, and the ERK activator fisetin could effectively attenuate the inhibitory role of FOXO3a on ERK.
CONCLUSIONS: Taken together, our results identified that hypoxia-induced extranuclear localization of FOXO3a promoted cell migration and invasion of human PC by modulating the DUSP6/ERK pathway. 2021 Journal of Gastrointestinal Oncology. All rights reserved.

Entities:  

Keywords:  ERK signaling pathway; Pancreatic cancer (PC); forkhead box O3a (FOXO3a); hypoxia; metastasis

Year:  2021        PMID: 34532120      PMCID: PMC8421878          DOI: 10.21037/jgo-21-359

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  39 in total

1.  Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor.

Authors:  A Brunet; A Bonni; M J Zigmond; M Z Lin; P Juo; L S Hu; M J Anderson; K C Arden; J Blenis; M E Greenberg
Journal:  Cell       Date:  1999-03-19       Impact factor: 41.582

Review 2.  Hypoxia--a key regulatory factor in tumour growth.

Authors:  Adrian L Harris
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

3.  Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors.

Authors:  Geert J P L Kops; Rene H Medema; Janet Glassford; Marieke A G Essers; Pascale F Dijkers; Paul J Coffer; Eric W-F Lam; Boudewijn M T Burgering
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

4.  LncRNA GAS6-AS2 facilitates tumor growth and metastasis of hepatocellular carcinoma by activating the PI3K/AKT/FoxO3a signaling pathway.

Authors:  Cancan Liang; Lan Pang; Yue Ke; Wenjing Ji; Jingping Xiong; Rong Ding; Yongnian Ding
Journal:  Int J Clin Exp Pathol       Date:  2019-11-01

5.  Hypoxia induces FoxO3a-mediated dysfunction of blood-brain barrier.

Authors:  Soo-Wang Hyun; Yi-Sook Jung
Journal:  Biochem Biophys Res Commun       Date:  2014-07-17       Impact factor: 3.575

Review 6.  FOXO transcription factors in cancer development and therapy.

Authors:  Alexandra Coomans de Brachène; Jean-Baptiste Demoulin
Journal:  Cell Mol Life Sci       Date:  2015-12-19       Impact factor: 9.261

7.  FOXO3a-dependent Parkin regulates the development of gastric cancer by targeting ATP-binding cassette transporter E1.

Authors:  Dan Ding; Xiang Ao; Mengyang Li; Shuo Miao; Ying Liu; Zhijuan Lin; Mengyu Wang; Yuqi He; Jianxun Wang
Journal:  J Cell Physiol       Date:  2020-09-10       Impact factor: 6.384

8.  MiRNA-96 accelerates the malignant progression of ovarian cancer via targeting FOXO3a.

Authors:  N Yang; Q Zhang; X-J Bi
Journal:  Eur Rev Med Pharmacol Sci       Date:  2020-01       Impact factor: 3.507

9.  Artesunate promotes the proliferation of neural stem/progenitor cells and alleviates Ischemia-reperfusion Injury through PI3K/Akt/FOXO-3a/p27kip1 signaling pathway.

Authors:  Kaiyuan Zhang; Yang Yang; Hongfei Ge; Ju Wang; Xuezhu Chen; Xuejiao Lei; Jun Zhong; Chao Zhang; Jishu Xian; Yongling Lu; Liang Tan; Hua Feng
Journal:  Aging (Albany NY)       Date:  2020-05-07       Impact factor: 5.682

10.  Inhibition of PTEN Gene Expression by Small Interfering RNA on PI3K/Akt/FoxO3a Signaling Pathway in Human Nasopharyngeal Carcinoma.

Authors:  Liang Zhong Yao; Yan Li Zhu; Jun Jie Liu
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
View more
  1 in total

1.  FOXO3a‑modulated DEPDC1 promotes malignant progression of nephroblastoma via the Wnt/β‑catenin signaling pathway.

Authors:  Geng Geng; Qinghao Li; Xingqing Guo; Qingbin Ni; Yongtao Xu; Zhaolong Ma; Yongjin Wang; Ming Ming
Journal:  Mol Med Rep       Date:  2022-07-07       Impact factor: 3.423

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.